1-5 of 5
Mark A. Catherwood
Close
Sort by
Journal Articles

CD26 (Dipedtidyl Peptidase IV) Expression in B-CLL.

Leeona Galligan, PhD, Mark A. Catherwood, PhD, Treen C. Morris, H. Denis Alexander
Journal: Blood
Blood (2007) 110 (11): 4699.
https://doi.org/10.1182/blood.V110.11.4699.4699
Published: 2007
Journal Articles

TCR Gene Rearrangement in B-Cell Chronic Lymphocytic Leukaemia.

Mark A. Catherwood, PhD, Leeona Galligan, PhD, David Gonzalez, PhD, Treen C. Morris, MD, H. Denis Alexander, DPhil
Journal: Blood
Blood (2007) 110 (11): 4700.
https://doi.org/10.1182/blood.V110.11.4700.4700
Published: 2007
Journal Articles

Mutated IGHV 1-69 B-CLL Patients Have Indolent Disease and Short CDR3 Sequences.

Leeona Galligan, PhD, Mark A. Catherwood, PhD, Treen C. Morris, MD, H. Denis Alexander, DPhil
Journal: Blood
Blood (2007) 110 (11): 4695.
https://doi.org/10.1182/blood.V110.11.4695.4695
Published: 2007
Journal Articles

ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)

Sarah J. Richardson, Christine Matthews, Mark A. Catherwood, H. Denis Alexander, B. Sean Carey, Joanna Farrugia, Anne Gardiner, Sarah Mould, David Oscier, J. Adrian Copplestone, Archibald G. Prentice
Journal: Blood
Blood (2006) 107 (9): 3584–3592.
https://doi.org/10.1182/blood-2005-04-1718
Published: 2006
Journal Articles

Serum Thymidine Kinase Levels, lgV H Mutational Status and Cytogenetic Aberrations in B-CLL.

Christine Matthews, BSc, Mark A. Catherwood, PhD, Treen C.M. Morris, MD FRCPI FRCPath, Denis Alexander, DPhil MRCPath
Journal: Blood
Blood (2004) 104 (11): 4803.
https://doi.org/10.1182/blood.V104.11.4803.4803
Published: 2004